Snapshot from Jul 19, 2026 at 14:14 UTC. For live data and tracking: View Live
Events / Regulatory / GRAIL securities class action lawsuit
Regulatory securities class action

GRAIL securities class action lawsuit

Analysis based on 14 articles · First reported Jun 09, 2026 · Last updated Jul 14, 2026

Sentiment
-60
Attention
2
Articles
14
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

Illumina — Holy Grail's stock price collapsed 50.55% after the trial failure announcement, erasing billions in market value. The class action lawsuit may result in significant financial liability for the company, further pressuring its stock.

biotechnology healthcare
Event Summary

Illumina — Holy Grail, Inc. (Nasdaq: GRAL) is facing a securities class action lawsuit filed by The Gross Law Firm on behalf of shareholders who purchased shares between May 13, 2025 and February 19, 2026. The complaint alleges that Illumina — Holy Grail made false and misleading statements regarding its NHS-Galleri trial, concealing that the trial was insufficient to demonstrate a reduction in Stage III-IV cancers. On February 19, 2026, Illumina — Holy Grail announced the trial failed to meet its primary endpoint, causing its stock price to drop 50.55% in one day from $101.53 to $50.21. The deadline to seek lead plaintiff is August 4, 2026.

Key Actions
99 Illumina — Holy Grail announced trial endpoint not observed
88 Pomerantz LLP filed class action lawsuit Illumina — Holy Grail
85 Bronstein, Gewirtz & Grossman, LLC filed class action lawsuit Illumina — Holy Grail
85 The Law Offices of Frank R. Cruz filed class action lawsuit Illumina — Holy Grail
82 Rosen Law Firm announced class action lawsuit Illumina — Holy Grail
81 Bleichmar Fonti & Auld LLP filed lawsuit Illumina — Holy Grail
76 Glancy Prongay & Murray filed lawsuit Illumina — Holy Grail
Entities Involved
subs
Illumina — Holy Grail
Illumina — Holy Grail is the defendant in the securities class action; its stock plummeted after the trial failure and faces legal and reputational damage.
Importance 100.0 Sentiment -80.0
exch
Nasdaq
Nasdaq is the exchange where Illumina — Holy Grail is listed; the event does not directly affect Nasdaq.
Importance 10.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.